NCT03610373

Brief Summary

Youth depression and anxiety represent a serious public health concern, with affected youth often experiencing social, familial, and academic impairment. Research evidence supports a growing array of effective treatments for youth depression and anxiety, yet as the collection of evidence-based treatments expands, so do the challenges of utilizing the evidence: clinicians must be able to (1) access, integrate, and apply the available evidence, and (2) engage in a collaborative process with each family to develop a plan that is responsive to each family's unique characteristics, preferences, and goals. Engaging caregivers and youths as active collaborators in the treatment planning process is a patient-centered approach with the potential to improve the process and outcome of youth mental health care by facilitating the personalization of established evidence-based treatment approaches. Such collaboration, frequently referred to as shared decision-making (SDM), is a hallmark of evidence-based practice and a key feature of federal guidelines for health care delivery. However, despite growing rhetorical support for SDM, empirical support is lacking, particularly in the area of youth mental health treatment. The absence of such research is unfortunate, given the potential for SDM to facilitate the dissemination and implementation of evidence-based treatments, and to personalize the use of established treatments to increase acceptability, retention, satisfaction, and overall effectiveness. The present project tests the feasibility and acceptability of SDM through a pilot randomized controlled trial of 40 youths (ages 7-15) meeting diagnostic criteria for an anxiety or depressive disorder. The trial will compare an evidence-based treatment that is planned collaboratively with youths and caregivers using the SDM protocol, to an evidence-based treatment that is planned by the clinician and supervisor using pretreatment assessment data. Eligible youths will received up to 26 treatment sessions at no cost and complete assessments prior to the start of treatment, at the end of treatment, and six months following the end of treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2016

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2019

Completed
Last Updated

January 28, 2020

Status Verified

January 1, 2020

Enrollment Period

2.4 years

First QC Date

June 29, 2018

Last Update Submit

January 27, 2020

Conditions

Keywords

anxietydepressionchildhoodtherapytreatmentmedical decision making

Outcome Measures

Primary Outcomes (1)

  • Anxiety Disorders Interview Schedule for DSM-IV - Child/Parent

    The Anxiety Disorders Interview Schedule for DSM-IV - Child/Parent is an extensively tested semi-structured interview assessing the major anxiety, mood, and externalizing disorders.

    Through completion of treatment, anticipated to be an average of 5 months

Secondary Outcomes (1)

  • Satisfaction with Decision Scale

    At the start of treatment, anticipated to be an average of 3 weeks after the initial assessment

Study Arms (2)

Shared Decision Making

EXPERIMENTAL

In this arm, parents and children will participate in a shared decision-making protocol with the clinician to plan their treatment. The treatment options available are established, evidence-based treatment techniques. The shared decision-making protocol was developed for this research project.

Behavioral: Modular Approach to Therapy for Children (MATCH)

Clinician Guided

ACTIVE COMPARATOR

In this arm, the clinician will plan the treatment in consultation with their supervisor, and share the treatment plan with the parent and child. The parent and child will have the opportunity to ask questions about the treatment plan (and, if they do not agree, reject the treatment plan), but they are not actively involved in making each decision. This is more typical of usual care.

Behavioral: Modular Approach to Therapy for Children (MATCH)

Interventions

MATCH is a collection of 31 modules that correspond to the treatment procedures included in standard evidence-based treatments for youth depression, anxiety, and behavioral disorders.

Clinician GuidedShared Decision Making

Eligibility Criteria

Age7 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • a current DSM-5 principal diagnosis of a Major Depressive Disorder, Dysthymic Disorder, Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Phobia, or Specific Phobia
  • if receiving psychiatric medication, dose will be stable for at least 3 months at enrollment with ability to maintain medication
  • youth and caregiver speak fluent English

You may not qualify if:

  • active suicidality
  • history of severe physical or mental impairments (e.g., mental retardation, autism spectrum disorders) in youth or caregiver
  • participation in additional psychosocial treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston University

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Anxiety DisordersDepressive DisorderDepression

Condition Hierarchy (Ancestors)

Mental DisordersMood DisordersBehavioral SymptomsBehavior

Study Officials

  • David A Langer, Ph.D.

    Boston University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessors do not have access to data regarding which arm each participant is in.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to receive a treatment planned primarily by the clinician (clinician guided) or planned collaboratively by the clinician, parent, and child (shared decision-making).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

June 29, 2018

First Posted

August 1, 2018

Study Start

October 4, 2016

Primary Completion

February 20, 2019

Study Completion

August 27, 2019

Last Updated

January 28, 2020

Record last verified: 2020-01

Locations